Normosol-R

Product manufactured by Hospira, Inc.

Application Nr Approved Date Route Status External Links
NDA017586 1984-08-01 Intravenous RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Normosol-R Ph 7.4 Is Indicated For Replacement Of Acute Extracellular Fluid Volume Losses In Surgery, Trauma, Burns Or Shock. Normosol-R Ph 7.4 Also Can Be Used As An Adjunct To Restore A Decrease In Circulatory Volume In Patients With Moderate Blood Loss. Normosol-R Ph 7.4 Is Not Intended To Supplant Transfusion Of Whole Blood Or Packed Red Cells In The Presence Of Uncontrolled Hemorrhage Or Severe Reductions Of Red Cell Volume. Normosol-R Ph 7.4 Is Particularly Valuable As A Solution For Use In Starting Blood, I.e., As A Priming Solution For The Infusion Set. No Hemolysis Of Blood Is Seen At The Interface Or With Mixed Solution And Blood. It May Also Be Used As A Diluent To Aid In The Transfusion Of Packed Red Blood Cells (prbc). Normosol-R Ph 7.4 And Physiologic Saline Solution (0.9% Sodium Chloride Injection, Usp) Are Compatible With Both Young And Old Prbc.

All Formulated Excipients (0 Total)

None

Comments